Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$13.7M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 9 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 33 most recent Form 4 transactions.
| May 28 | RANI | Rani Therapeutics… | AGRANT◆ | 123,600 | — | — | — | Open the original filing on SEC.gov |
| May 20 | ALNY | Alnylam Pharmaceuticals,… | AGRANT◆ | 1,441 | — | — | — | Open the original filing on SEC.gov |
| May 20 | ALNY | Alnylam Pharmaceuticals,… | AGRANT | 671 | — | — | +73.7% | Open the original filing on SEC.gov |
| Aug 14, 2025 | ALNY | Alnylam Pharmaceuticals,… | MEXER◷◆ | 3,454 | — | — | — | Open the original filing on SEC.gov |
| Aug 14, 2025 | ALNY | Alnylam Pharmaceuticals,… | MEXER◷◆ | 4,032 | — | — | — | Open the original filing on SEC.gov |
| Aug 14, 2025 | ALNY | Alnylam Pharmaceuticals,… | MEXER◷◆ | 5,228 | — | — | — | Open the original filing on SEC.gov |
| Aug 14, 2025 | ALNY | Alnylam Pharmaceuticals,… | MEXER◷◆ | 4,581 | — | — | — | Open the original filing on SEC.gov |
| Aug 14, 2025 | ALNY | Alnylam Pharmaceuticals,… | MEXER◷◆ | 5,153 | — | — | — | Open the original filing on SEC.gov |
| Aug 14, 2025 | ALNY | Alnylam Pharmaceuticals,… | MEXER◷◆ | 9,000 | — | — | — | Open the original filing on SEC.gov |
| Aug 14, 2025 | ALNY | Alnylam Pharmaceuticals,… | SSELL◷ | 641 | $442.66 | $283.7K | -41.3% | Open the original filing on SEC.gov |
| Aug 14, 2025 | ALNY | Alnylam Pharmaceuticals,… | SSELL◷ | 1,205 | $441.88 | $532.5K | -43.7% | Open the original filing on SEC.gov |
| Aug 14, 2025 | ALNY | Alnylam Pharmaceuticals,… | SSELL◷ | 1,238 | $440.54 | $545.4K | -31.0% | Open the original filing on SEC.gov |
| Aug 14, 2025 | ALNY | Alnylam Pharmaceuticals,… | SSELL◷ | 5,302 | $439.27 | $2.3M | -57.0% | Open the original filing on SEC.gov |
| Aug 14, 2025 | ALNY | Alnylam Pharmaceuticals,… | SSELL◷ | 2,086 | $438.34 | $914.4K | -18.3% | Open the original filing on SEC.gov |
| Aug 14, 2025 | ALNY | Alnylam Pharmaceuticals,… | SSELL◷ | 1,922 | $437.56 | $841K | -14.4% | Open the original filing on SEC.gov |
| Aug 14, 2025 | ALNY | Alnylam Pharmaceuticals,… | SSELL◷ | 5,358 | $436.00 | $2.3M | -28.7% | Open the original filing on SEC.gov |
| Aug 14, 2025 | ALNY | Alnylam Pharmaceuticals,… | SSELL◷ | 7,675 | $435.40 | $3.3M | -29.1% | Open the original filing on SEC.gov |
| Aug 14, 2025 | ALNY | Alnylam Pharmaceuticals,… | SSELL◷ | 2,098 | $434.50 | $911.6K | -7.4% | Open the original filing on SEC.gov |
| Aug 14, 2025 | ALNY | Alnylam Pharmaceuticals,… | SSELL◷ | 1,938 | $432.94 | $839K | -6.4% | Open the original filing on SEC.gov |
| Aug 14, 2025 | ALNY | Alnylam Pharmaceuticals,… | SSELL◷ | 1,985 | $430.81 | $855.2K | -6.1% | Open the original filing on SEC.gov |
| Aug 14, 2025 | ALNY | Alnylam Pharmaceuticals,… | MEXER◷ | 3,454 | $189.87 | $655.8K | +11.9% | Open the original filing on SEC.gov |
| Aug 14, 2025 | ALNY | Alnylam Pharmaceuticals,… | MEXER◷ | 4,032 | $171.95 | $693.3K | +16.2% | Open the original filing on SEC.gov |
| Aug 14, 2025 | ALNY | Alnylam Pharmaceuticals,… | MEXER◷ | 5,228 | $151.22 | $790.6K | +26.6% | Open the original filing on SEC.gov |
| Aug 14, 2025 | ALNY | Alnylam Pharmaceuticals,… | MEXER◷ | 4,581 | $148.77 | $681.5K | +30.4% | Open the original filing on SEC.gov |
| Aug 14, 2025 | ALNY | Alnylam Pharmaceuticals,… | MEXER◷ | 5,153 | $128.31 | $661.2K | +52.0% | Open the original filing on SEC.gov |
| Aug 14, 2025 | ALNY | Alnylam Pharmaceuticals,… | MEXER◷ | 9,000 | $72.01 | $648.1K | +987.9% | Open the original filing on SEC.gov |
| Jul 1, 2025 | MCRB | Seres Therapeutics, Inc. | AGRANT◆ | 6,452 | — | — | — | Open the original filing on SEC.gov |
| May 28, 2025 | RANI | Rani Therapeutics… | AGRANT◆ | 50,000 | — | — | — | Open the original filing on SEC.gov |
| May 8, 2025 | ALNY | Alnylam Pharmaceuticals,… | AGRANT◆ | 1,558 | — | — | — | Open the original filing on SEC.gov |
| May 8, 2025 | ALNY | Alnylam Pharmaceuticals,… | AGRANT | 775 | — | — | +569.9% | Open the original filing on SEC.gov |
| Apr 10, 2025 | MCRB | Seres Therapeutics, Inc. | AGRANT◆ | 100,000 | — | — | — | Open the original filing on SEC.gov |